1. Hepatocellular carcinoma and hepatitis B virus;Beasley, R.P.; Hwang, L.Y.;Semin LiverDis,1984
2. Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in a high risk population in the United States;Szmuness, W.; Stevens, C.E.; Harlev, E.J.;N Engli Med,1980
3. Clinical evaluation in healthy adults of a hepatitis B vaccine made by recombinant DNA;Scolnick, E.M.; McLean, A.A.; West, D.J.; McAleer, W.J.; Miller, W.J.; Buynak, E.B.;JAMA,1984
4. Seroprevalence of hepatitis B virus infection in children in Taipei, 1989: five years after a mass hepatitis B vaccination program;Tsen, Y.-J.; Chang, M.-H.; Hsu, H.-Y.; Lee, C.-Y.; Sung, J.-L.; Chen, D.-S.;Med Virol,1991
5. The changing epidemiology of hepatitis B in the United States;Alter, M.J.; Hadler, S.C.; Margolis, H.S.;jAMA,1990